IN2014CN04655A - - Google Patents

Info

Publication number
IN2014CN04655A
IN2014CN04655A IN4655CHN2014A IN2014CN04655A IN 2014CN04655 A IN2014CN04655 A IN 2014CN04655A IN 4655CHN2014 A IN4655CHN2014 A IN 4655CHN2014A IN 2014CN04655 A IN2014CN04655 A IN 2014CN04655A
Authority
IN
India
Application number
Inventor
Alain Francis Claude Vanderplasschen
Original Assignee
Université de Liège
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université de Liège filed Critical Université de Liège
Publication of IN2014CN04655A publication Critical patent/IN2014CN04655A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16041Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16061Methods of inactivation or attenuation
    • C12N2710/16062Methods of inactivation or attenuation by genetic engineering
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/20Pseudochromosomes, minichrosomosomes
    • C12N2800/204Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
IN4655CHN2014 2011-12-30 2014-06-19 IN2014CN04655A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11196171 2011-12-30
PCT/EP2012/076496 WO2013098214A1 (en) 2011-12-30 2012-12-20 A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv

Publications (1)

Publication Number Publication Date
IN2014CN04655A true IN2014CN04655A (en) 2015-09-18

Family

ID=47429841

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4655CHN2014 IN2014CN04655A (en) 2011-12-30 2014-06-19

Country Status (18)

Country Link
US (2) US20140348875A1 (en)
EP (1) EP2797627B1 (en)
JP (3) JP5982009B2 (en)
CN (1) CN104159609B (en)
BR (1) BR112014016117A2 (en)
HU (1) HUE053075T2 (en)
IL (1) IL232902A0 (en)
IN (1) IN2014CN04655A (en)
MD (1) MD4481C1 (en)
MX (1) MX361408B (en)
PH (1) PH12014501388A1 (en)
PL (1) PL2797627T3 (en)
RS (1) RS61261B1 (en)
RU (1) RU2662768C2 (en)
SG (1) SG11201403066TA (en)
TW (1) TWI484034B (en)
UA (2) UA114719C2 (en)
WO (1) WO2013098214A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2662768C2 (en) * 2011-12-30 2018-07-31 Гесвал с.а. RECOMBINANT Koi HERPESVIRUS (KHV) AND VACCINE FOR PREVENTION OF DISEASE CAUSED BY KHV
WO2017177071A1 (en) * 2016-04-08 2017-10-12 William Marsh Rice University Improved galactose utilization
RU2736472C2 (en) * 2016-11-18 2020-11-17 Общество с ограниченной ответственностью "ЭКСИФАРМ" Chimeric protein, a synthetic dna which codes said protein, an expression vector, a synthetic dna producing strain and a method of producing plasmid dna
CN112279897B (en) * 2018-11-05 2021-12-28 深圳技术大学 Reagent for preventing or treating fish infection CyHV-2 and application
EP3662929A1 (en) * 2018-12-07 2020-06-10 IDT Biologika GmbH A recombinant koi herpesvirus (khv) and a diva vaccine for preventing and/or treating a disease caused by khv
CN110101854B (en) * 2019-05-14 2022-08-02 四川农业大学 Carp herpesvirus III type vaccine and preparation method thereof
CN110468111B (en) * 2019-08-07 2022-06-17 西北农林科技大学 Recombinant baculovirus displaying CyHV-2 membrane protein and preparation method and application thereof
CN110452926B (en) * 2019-08-07 2022-06-17 西北农林科技大学 Recombinant baculovirus displaying CyHV-2 membrane protein and preparation method and application thereof
CN113679832A (en) * 2021-05-24 2021-11-23 苏州大学 Method for preparing baculovirus carp herpesvirus II type DNA vaccine by utilizing freeze drying
CN115960903B (en) * 2022-12-23 2023-09-08 中国水产科学研究院淡水渔业研究中心 Antisense RNA group, recombinant vector and nanoparticle delivery system for inhibiting proliferation of CyHV-2 virus and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068989T3 (en) 1989-02-04 1995-05-01 Akzo Nobel Nv TOCOLES AS AN ADJUVANT IN VACCINES.
DE19733364A1 (en) 1997-08-01 1999-02-04 Koszinowski Ulrich H Prof Method of cloning a large virus genome
IL153775A0 (en) * 2003-01-01 2003-07-31 Yissum Res Dev Co Immunizing fish against viral infection
JP2007223913A (en) * 2006-02-21 2007-09-06 Kyoritsu Seiyaku Kk Vaccine for carp-herpesvirus disease
JP5239023B2 (en) * 2006-04-13 2013-07-17 国立大学法人東京海洋大学 Koi herpesvirus (KHV) disease DNA vaccine
MD20100029A2 (en) * 2007-08-28 2010-08-31 Льежский Университет Recombinant KOI herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
DE102007041332A1 (en) * 2007-08-31 2009-03-05 Siemens Ag Transferchuck for transmission, especially wafers
RU2662768C2 (en) * 2011-12-30 2018-07-31 Гесвал с.а. RECOMBINANT Koi HERPESVIRUS (KHV) AND VACCINE FOR PREVENTION OF DISEASE CAUSED BY KHV

Also Published As

Publication number Publication date
RS61261B1 (en) 2021-01-29
MD4481B1 (en) 2017-05-31
MX361408B (en) 2018-12-04
JP5982009B2 (en) 2016-08-31
CN104159609B (en) 2018-05-22
TWI484034B (en) 2015-05-11
RU2662768C2 (en) 2018-07-31
EP2797627A1 (en) 2014-11-05
CN104159609A (en) 2014-11-19
EP2797627B1 (en) 2020-10-07
PH12014501388A1 (en) 2014-09-22
JP2016195593A (en) 2016-11-24
US20140348875A1 (en) 2014-11-27
JP2018078903A (en) 2018-05-24
IL232902A0 (en) 2014-07-31
TW201333201A (en) 2013-08-16
MD20120127A2 (en) 2013-07-31
JP2015503914A (en) 2015-02-05
BR112014016117A2 (en) 2018-09-25
US9931396B2 (en) 2018-04-03
HUE053075T2 (en) 2021-06-28
UA114719C2 (en) 2017-07-25
MD4481C1 (en) 2017-12-31
PL2797627T3 (en) 2021-06-28
UA119786C2 (en) 2019-08-12
WO2013098214A1 (en) 2013-07-04
US20170028057A1 (en) 2017-02-02
RU2014131474A (en) 2016-02-20
MX2014008045A (en) 2014-10-24
SG11201403066TA (en) 2014-10-30

Similar Documents

Publication Publication Date Title
AP3853A (en)
BR112013031251A2 (en)
BR112013027245A2 (en)
BR112013026905A2 (en)
BR112013023185A2 (en)
BR112013026744A2 (en)
BR112013023927A2 (en)
BR112013027830A2 (en)
BR122021002201A2 (en)
BR112013028733A2 (en)
BR112013027121A2 (en)
BR112013027452A2 (en)
BR112013031556A2 (en)
BR112013026790A2 (en)
BR112013024588A2 (en)
BR112013032380A2 (en)
BR112013032377A2 (en)
BR112013032368A2 (en)
BR112013026895A2 (en)
BR112013027761A2 (en)
BR112013027836A2 (en)
BR112013032392A2 (en)
BR112013025487A2 (en)
IN2014CN04655A (en)
BR112013027871A2 (en)